Estimation of the Diaphragm Electrical Activity and Intercostal Thickening Fraction During Different Pattern of Mechanical Ventilation: PSV Versus NAVA

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

the introduction of new MV modalities has shown promising results in reducing the incidence of weaning failure, mainly due to a more physiologic approach which allows respiratory muscle preservation. Among them, the Neurally Adjust Ventilatory Assist (NAVA) seemed to be associated with lower incidence of weaning failure and subsequent duration of mechanical ventilation, compared to standard modalities like the Pressure Support Ventilation (PSV) . Moreover, NAVA allows the evaluation of the diaphragm electrical activity (EAdi), an index of diaphragmatic neural respiratory drive. However, no study has compared TFic values during PSV and NAVA modalities in patients with difficult weaning from MV admitted in ICU.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients who have failed at least one weaning attempt

mechanical ventilation for at least 24 hours

Disqualifiers

Pregnancy

Obesity (Body Mass Index > 35 kg/m2)

Contraindication to the insert of a nasogastric tube

Neuromuscular diseases

Trial population

Critically ill patients on mechanical ventilation (MV) for at least 24 hours, who have failed at least one weaning attempt, hospitalized at the Intensive Care Unit of Fondazione Policlinico Universitario A. Gemelli IRCCS.

Trial design

Design model

Case-crossover

Time perspective

Prospective

Treatments tested in this trial

  • difficult weaning patients

    Other intervention

    intercostal thickening fraction values during PSV and NAVA modalities in patients with difficult weaning from MV admitted in ICU.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

intercostal thickening fraction

intercostal thickening fraction values during PSV and NAVA

Time frame
From date of enrollment until the date of extubation (up to seven days)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.